Skip to content
  • There are no suggestions because the search field is empty.

 

Medical Affairs & HEOR

Trio’s tech-enabled solution offers both retrospective data and prospective data collection, and real-time patient surveillance. We help you to understand real-world clinical performance and identify opportunities for improvement. 

1-Mar-23-2023-06-00-09-1426-PM
Patient-level clinical insights; prospective & retrospective
1-Mar-24-2023-02-28-34-9913-PM
Analyze efficacy in understudied patient cohorts
3-Mar-24-2023-02-28-34-9913-PM
Refine medical
affairs and
MSL strategy
2-Mar-24-2023-02-28-34-9922-PM
Better understand safety and improve pharmacovigilance
categories of trio health publications. clinical outcomes, patient voice, treatment safety, market access and payer strategy, linking via datavant token
200+ peer reviewed publications since inception. 125+ clinical, 45+ patient voice, 20+ access to care, 10+ safety

Our Competitive Advantage 

Ability to monitor real-world drug usage and safety in real-time

Direct EMR access to identify unmet patient needs at the physician/practice level

Access to the physician and patient voice to understand the why behind treatment decisions

Scientific Steering Committees (SSCs) comprised of highly respected, disease-specific key opinion
leaders (KOLs) to identify key research trends to support innovative study designs

Linking data via Datavant Tokens to supplement data and insights

1-Mar-24-2023-02-55-02-5964-PM
3-Mar-24-2023-02-55-02-6227-PM
2-Mar-24-2023-02-55-02-6454-PM

Explore Other Trio Services